greviainvag.com

Greviainvag.com operates under the business name Grevia Investment AG and presents itself as an institutional private credit management firm. The website provides limited information about the company’s history, with the domain registered on an undisclosed date and no clear country of registration.

According to the Swiss Financial Market Supervisory Authority (FINMA), the entity is domiciled in Baar, Switzerland, but is not entered in the commercial register. FINMA has issued a public warning against greviainvag.com, stating that it is not supervised by FINMA and may be conducting unauthorized activities.

Our review confirms that Greviainvag.com holds no regulatory licenses from any recognized financial authority. The FINMA warning list entry explicitly notes the absence of commercial registration and warns consumers about potential unauthorized services.

In addition, aggregated industry databases classify this entity as high-risk due to the lack of oversight. A Medium article published in 2026 alleges that $94,000 was stolen in a healthcare investment scam involving greviainvag.com, though this claim has not been independently verified by FXCanary.

The broker’s website highlights two main service lines: commercial lending and business loan solutions. These are described as targeting businesses in need of cash flow and growth capital, with a focus on the lower middle-market segment.

The platform claims to use technology to originate and acquire short- and long-term loans, but no specific loan terms, interest rates, or eligibility criteria are disclosed. There is no mention of retail forex, CFDs, or other trading instruments typically associated with forex brokers.

Given its institutional focus, Greviainvag.com appears aimed at business borrowers or institutional investors seeking private credit opportunities. The website offers no multilingual support, educational resources, or retail trading accounts.

For individual traders or investors, the lack of regulation, transparent fee structure, and verifiable track record makes this entity unsuitable. The FINMA warning and scam allegations further underscore the risks for unsophisticated participants.

The most critical risk factor is the absence of regulatory oversight. The FINMA warning indicates that the entity is not authorized to provide financial services in Switzerland, raising concerns about its legitimacy.

Furthermore, the reported theft of $94,000 in a healthcare investment scam, if accurate, suggests a pattern of fraudulent activity. Traders and investors should be aware that engaging with unregulated financial firms carries elevated risks of loss and limited recourse.